Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit

Chemoprevention of prostate cancer by second-generation selenium compounds in reference to selenomethionine holds strong promise to deal with the disease at the root. Here we used the transgenic adenocarcinoma mouse prostate (TRAMP) model to establish the efficacy of methylseleninic acid (MSeA) and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wang, Lei, Bonorden, Melissa J. L., Li, Guang-xun, Lee, Hyo-Jeong, Hu, Hongbo, Zhang, Yong, Liao, Joshua D., Cleary, Margot P., Lü, Junxuan
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2822708/
https://ncbi.nlm.nih.gov/pubmed/19401524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0173
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares